Anticancer effects of imatinib via immunostimulation

Nature Medicine

Volumn 17, Issue 9, 2011, Pages 1050-1051

  Zitvogel, Laurence ^a,b,c,d   Kroemer, Guido ^c,e,f,g,h  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSERM   (France)

^c IGR   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e Institut Gustave Roussy   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; INTERFERON;

ANTINEOPLASTIC ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; IMMUNOTHERAPY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT RESPONSE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOTHERAPY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; PIPERAZINES; PYRIMIDINES; T-LYMPHOCYTES, REGULATORY;

EID: 80052496590     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2429     Document Type: Short Survey

References (12)

1. Hanahan, D. & Weinberg, R.A. Cell 144, 646-674 (2011).
2. Pierotti, M.A., Tamborini, E., Negri, T., Pricl, S. & Pilotti, S. Nat. Rev. Clin. Oncol. 8, 161-170 (2011).
3. Balachandran, V.P. et al. Nat. Med. 17, 1094-1100 (2011).
4. Taieb, J. et al. Nat. Med. 12, 214-219 (2006).
5. Borg, C. et al. J. Clin. Invest. 114, 379-388 (2004).
6. Delahaye, N.F. et al. Nat. Med. 17, 700-707 (2011).
7. Ghiringhelli, F. et al. J. Exp. Med. 202, 1075-1085 (2005).
8. Okada, M. et al. Blood 103, 2299-2307 (2004).
9. Zitvogel, L., Kepp, O. & Kroemer, G. Cell 140, 798-804 (2010).
10. Mohty, M. et al. Blood 103, 4666-4668 (2004).
11. Catellani, S., Pierri, I., Gobbi, M., Poggi, A. & Zocchi, M.R. PLoS ONE 6, e18925 (2011).
12. Preudhomme, C. et al. N. Engl. J. Med. 363, 2511-2521 (2010).